It is therefore difficult to predict based on the current knowledge how PI3K-Akt-mTOR inhibition will alter the ability of MSCs to communicate and thereby support AML cells in the BM niches through direct cell-cell contact or through their release of soluble mediators. This evidence concerns the gene AKT1 and acute myeloid leukemia.